Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a PubMed auto-fill note stating that publications may not be about the study and included a page revision tag (v3.3.2). Removed the prior PubMed-source note and the older revision tag (v3.2.0).SummaryDifference0.1%

- Check20 days agoChange DetectedThe funding lapse notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedMinor formatting/layout adjustments observed; no changes to core study data (title, conditions, interventions, eligibility criteria, or primary outcomes). To avoid being alert by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

- Check70 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.0%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, indicating a minor core-content update; the 'Back to Top' link was removed as a small UI change.SummaryDifference0.1%

Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.